findmyKOL
Clinical trialNCT03990883CompletedInterventional

Effectiveness and Safety of Princess FILLER Lidocaine in Correction of Nasolabial Folds (NLF)

SponsorCroma-Pharma GmbHEnrollment295Dermatological Non-Disease
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

Clinical Investigation to demonstrate the effectiveness and safety of Princess Filler Lidocaine in the correction of moderate to severe nasolabial folds

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

11 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Gary Monheit

    Birmingham, Alabama, United States

  • John Joseph

    Beverly Hills, California, United States

  • Sabrina Fabi

    San Diego, California, United States

  • Ava Shamban

    Santa Monica, California, United States

  • Joel Cohen

    Greenwood Village, Colorado, United States

  • Jeremy Green

    Coral Gables, Florida, United States

  • Robert Weiss

    Hunt Valley, Maryland, United States

  • Jeanine Downie

    Montclair, New Jersey, United States

  • the Center for Dermatology Cosmetic and Laser Surgery

    New York, New York, United States

  • Susan Taylor

    Philadelphia, Pennsylvania, United States

  • Michael Gold

    Nashville, Tennessee, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
4 Jun 2019
Primary completion
29 May 2020
Completion
15 Feb 2022
Last update posted
4 Feb 2025
Registered enrollment
295
Registry id
NCT03990883

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.